Development of Pulmonary Hypertension In Preterm Infants Treated with Laser versus anti-Vascular Endothelial Growth Factor therapy for Retinopathy of Prematurity: A Comparative Safety Study

Sunday, April 24, 2022

8:30 AM – 8:45 AM US MT

Location: Convention Center: Mile High Ballroom 4AB

CE: Enduring CME: 0.25

Publication Number: 2165.3

Christopher R. Nitkin, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Nicolas A. Bamat, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Joanne M. Lagatta, Medical College of Wisconsin, Milwaukee, WI, United States; Sara B. DeMauro, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Henry Lee, Stanford University, Stanford, CA, United States; Ravi M. Patel, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Brian King, UPMC Childrens Hospital of Pittsburgh, Pittsburgh, PA, United States; Jonathan L. Slaughter, Nationwide Children's Hospital/The Ohio State University, Columbus, OH, United States; J. Peter Campbell, Oregon Health & Science University School of Medicine, Portland, OR, United States; Troy Richardson, Analytics, Lenexa, KS, United States; Tamorah Lewis, University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada

Presenting Author(s)

Christopher R. Nitkin, MD
Assistant Professor
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Christopher R. Nitkin, MD: ● United Therapeutics (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).

Nicolas A. Bamat, MD MSCE: ● Wolters Kluwer Health (UptoDate) (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).

Joanne M. Lagatta, MD MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sara B. DeMauro, MD, MSCE: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Henry Lee, MD: ● Lansinoh Laboratories, Inc. (Ended In the Past 24 Months) (Products/Services: Advisory Committee).
● Mead Johnson Nutrition (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).

Ravi M. Patel, MD, MSc: ● Infant Bacterial Therapeutics / Premier Research (Currently Ongoing) (Products/Services: Consultant).

Brian King, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jonathan L. Slaughter, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

J. Peter Campbell, MD, MPH: ● Boston AI (Ended In the Past 24 Months) (Products/Services: Consultant).
● Genentech (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).

Troy Richardson, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Tamorah Lewis, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.